.jpg)
EU-UK Spotlight: Renewables, trade, and the global supply chain
Competition authorities are increasingly rigorous and sophisticated in their review of transactions. Effective merger control requires careful legal strategy, early planning, and cross-border coordination. Hogan Lovells offers clients expert advice on navigating merger filings, investigations, and remedies across jurisdictions. Whether your deal triggers review thresholds in the EU, the U.K., the U.S., or emerging markets, we help anticipate regulatory objections, design mitigation strategies, and defend approval applications.
Our team supports clients of all sizes – corporates, private equity, financial institutions – through mergers, acquisitions, joint ventures, and other transactions that implicate competition law. With Hogan Lovells, you gain depth of experience in managing evolving enforcement trends with precision and commercial awareness.
Key contacts
Representative experience
Represented UnitedHealth Group in DOJ challenge to $13 billion acquisition of Change Healthcare; awarded Merger Control Matter of the Year by Global Competition Review.
Represented ASSA ABLOY in DOJ challenge to $4 billion acquisition of HHI division of Spectrum Brands; first DOJ consent decree in Biden administration.
Represented Within Unlimited in its acquisition by Meta Platforms Inc.
Represented Kustomer Inc., in its acquisition by Meta Platforms Inc.
Represented IBM in its acquisition of Red Hat.
Represented Albert Einstein Medical Center in FTC challenge to merger with Thomas Jefferson University; first FTC hospital merger trial loss in decades.
Represented ITA Software in its acquisition by Google.
Represented AdMob in its acquisition by Google.
You may also be interested in...
In-person event
ABA’s Antitrust in Healthcare Conference
20 May 2026 | 8:00 a.m. - 6:00 p.m. (EST)
United States
Webinar
The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from the U.S. navigate through it?
26 September 2023 | 5:00 PM - 6:00 PM (CEST)
Hogan Lovells Events
The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from Asia navigate through it?
20 June 2023 | 9:30 a.m. - 10:30 a.m. (CEST)
In-person event
ABA’s Antitrust in Healthcare Conference
20 May 2026 | 8:00 a.m. - 6:00 p.m. (EST)
United States
Webinar
The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from the U.S. navigate through it?
26 September 2023 | 5:00 PM - 6:00 PM (CEST)
Hogan Lovells Events
The EU Foreign Subsidy Regulation, in between burden, threat, and opportunity – How should undertakings operating from Asia navigate through it?
20 June 2023 | 9:30 a.m. - 10:30 a.m. (CEST)
